Live from the NIH registry
Studies recruiting near Stockton right now
Top 25 of 99 recruiting studies, sorted by proximity — each links to its official registry page
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Stockton Hematology Oncology Group — Stockton, California (1.7 mi)
· Sponsor: Pfizer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma
Phase 2
Interventional 146 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: NRG Oncology
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
Distance-Based Exercise to Preserve Function and Prevent Disability
Localized Malignant Solid Neoplasm, Anal Cancer
N/A
Interventional 104 participants sought
Kaiser Permanente-Modesto — Modesto, California (28.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (28.9 mi)
· Sponsor: vTv Therapeutics
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Aromatherapy and Its Impact on Preoperative Anxiety, Postoperative Pain, and Patient Experience
Postoperative Pain, Preoperative Anxiety
N/A
Interventional 286 participants sought
Kaiser Permanente Stockton Ambulatory Surgery Unit — Stockton, California (1.7 mi)
· Sponsor: Kaiser Permanente
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Neoplasms, Head and Neck
Phase 3
Interventional 864 participants sought
GSK Investigational Site — Stockton, California (1.7 mi)
· Sponsor: GlaxoSmithKline
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (28.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Respiratory Syncytial Virus Infections
Phase 2
Interventional 192 participants sought
Central Valley Research — Modesto, California (28.9 mi)
· Sponsor: Shionogi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Kaiser Permanente-Stockton — Stockton, California (1.7 mi)
· Sponsor: SWOG Cancer Research Network
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
Retinal Consultants Medical Group - Modesto — Modesto, California (28.9 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: NRG Oncology
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor
Phase 2
Interventional 141 participants sought
Saint Joseph's Medical Center — Stockton, California (1.7 mi)
· Sponsor: SWOG Cancer Research Network
Vancomycin Reduction Practices (VRP) in the NICU
Antibiotic Stewardship, Neonatal Sepsis, Late-Onset
N/A
Interventional 13 participants sought
Kaiser Permanente Modesto Medical Center — Modesto, California (28.9 mi)
· Sponsor: Children's Hospital of Philadelphia
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Memorial Medical Center — Modesto, California (28.9 mi)
· Sponsor: SWOG Cancer Research Network